CERUCommercialism in Education Research Unit (formerly Center for the Analysis of Commercialism in Education)
CERUConservation Ecology Research Unit (University of Pretoria, South Africa)
CERUCanadian Engineer Reinforcement Unit (WWII)
CERUCommander Emergency Recovery Unit
CERUChinese Economy Research Unit (Australia)
CERUCorrectional Emergency Response Unit (Canada)
References in periodicals archive ?
Reportedly, these awards were granted under the Cerus Corporation Inducement Plan, approved by the compensation committee of Cerus' board of directors, and were granted as an inducement material to Jayaraman's employment with Cerus, in accordance with Nasdaq Listing Rule 5635(c)(4).
Cerus has recently made regulatory progress in the US, Canada and Mexico, and is now excited about the prospect of accessing the North American market, said William Greenman, Cerus' president and CEO.
A live webcast of the presentation will be available from the Investor Relations page of the Cerus web site at http://www.
Completion of this transaction allows Cerus to focus organizational and financial resources solely on its core strengths in the blood safety business," comments Claes Glasswell, president and chief executive officer.
In a different approach to sidestepping the light-absorption problem, scientists at Cerus have developed a psoralen-like compound that's activated by acid instead of light.
Cerus and Baxter Healthcare Corporation are collaborating on the development of INTERCEPT Blood System to enhance the safety of blood transfusions.
chairman and chief executive officer of Baxter said, "We are very pleased with the significant progress of the Cerus and Baxter teams.
This financing significantly strengthens our balance sheet and provides additional resources to fund our research and development programs," said Stephen Isaacs, Cerus president and chief executive officer.
Under the agreement BioOne will receive approximately 1,170,000 shares of Cerus common stock valued at approximately USD3.
Baxter and Cerus expect to be the first to file for regulatory approval of a pathogen inactivation system for platelets," stated Harry M.
To access the live webcast, please visit the Investor Relations page of the Cerus website at http://www.
We are honored that Swiss Red Cross centers in Zurich and Lausanne have chosen INTERCEPT as their pathogen inactivation technology for plasma," said Caspar Hogeboom, president of Cerus Europe.